Solana ETF Filings Removed from CBOE Amid Denial Rumors

Joshua Ramos

In what is certainly a concerning development for the crypto market, Solana ETF filings have reportedly been removed from the Chicago Board Options Exchange (CBOE) website. That has led many to worry that the applications may be facing a delay from the US Securities and Exchange Commission (SEC). Or, even worse, a denial altogether.

Solana has been viewed as the token most likely to get the next crypto-based ETF in the US. This year has already seen Bitcoin and Ethereum get approved. However, it may be different this time. Speculation has swarmed that SOL could be viewed as a commodity. Therefore, making the ETF process increasingly complicated.

Solana
Source – CoinLoan

Also Read: Solana ETF Gets Green Signal From Brazil Regulator

SOL ETF Filings Disappear From CBOE Website as Concern Spreads

ETFs have been a focus of the crypto sector this year. Both BTC and ETH have broken ground on the investment offerings in 2024. Yet, traders are anxiously awaiting what tokens could be next. However, today has certainly threatened what has long been viewed as the next in line.

Solana ETF filings have been removed from the CBOE website today. Indeed, the removal sparked concerns over the ongoing application process. Specifically, regarding whether a denial has already taken place. Both VanEck and 21Shares have seen their SOL ETF applications absent.

Source: Decrypt

Also Read: Solana ETF Hopes Drive Price as SOL Approaches $200

Pseudonymous X (formerly Twitter) user SummersThings noted that both issuers’ July submissions are no longer listed. Moreover, they identified a rather confusing aspect of the filings. The user notes that the SEC “never issued Notices of Filling,” for both applications.

It places the prospect of a SOL ETF in the US into question. The market largely expected the product to debut at some point in 2025. Yet, that may no longer be likely. With Ethereum’s ETF off to a bumpy start, there may be many factors working against Solana when it comes to ETF approval.